Lilly v. FDA: Two Stories Collide to Make this GLP-1 Case a Tale of Our Time
By EsqSocial Corporation 15/01/25
I recently learned of Eli Lilly & Co.’s (“Lilly”) recent lawsuit against FDA from Nicole DeFeudis, who interviewed me for her Endpoints News story about the case. Lilly’s lawsuit, filed in September 2024 in the Southern District of Indiana (note: Lilly is headquartered in Indianapolis), challenges FDA’s decision to regulate Lilly’s trial product “retatrutide” as a drug rather than a biologic, which Lilly claims violated federal law and FDA’s own rules. Thank you, Nicole, for the heads up....
By: Fuerst Ittleman David & Joseph